Workflow · Production

NVIDIA BioNeMo end-to-end pipeline for generative protein binder design in drug discovery

The problem

Traditional protein binder design requires iterating through thousands of candidates via trial-and-error, with each synthesis and validation round taking months or even years, and a combinatorial search space of 20^430 possible sequences that is practically impossible to navigate by conventional methods.

Workflow diagram · grounded in source
1
Target structure prediction
ai_action
“By incorporating AlphaFold2 into the BioNeMo framework, researchers can achieve up to a 5x speedup in protein structure prediction, making large-scale target identification feasible in days rather than months”
2
De novo binder backbone and sequence generation
ai_action
“NVIDIA's integration of RFdiffusion within the BioNeMo framework accelerates inference by 1.9x, enabling rapid generation of protein backbones optimized for target binding”
3
Molecular docking prediction
ai_action
“DiffDock 2.0 enables researchers to predict molecular orientations 6.2 times faster and with 16% greater accuracy”
4
Stability validation
validation
“BioNeMo accelerates computations related to protein stability, such as changes in thermodynamic stability (ΔΔG) and melting temperature (ΔTm), facilitating rapid assessment of binder viability”
5
Functional testing and refinement
validation
“NVIDIA's Clara Discovery platform provides a collection of frameworks, applications, and AI models enabling GPU-accelerated computational drug discovery, allowing researchers to rapidly refine binder designs through distributed computing”
6
High-throughput in silico screening
output
“BioNeMo enables real-time in silico predictions, reducing the need for costly wet-lab experiments and accelerating lead optimization and ranking”
Reported outcome

The BioNeMo pipeline achieves up to 5x speedup in protein structure prediction (days rather than months), 1.9x faster backbone generation with RFdiffusion, and 6.2x faster molecular docking at 16% greater accuracy with DiffDock 2.0, while reducing reliance on costly wet-lab experiments.

Reported metrics
Protein structure prediction speedupup to 5x
Target identification timelinefeasible in days rather than months
RFdiffusion inference speedup1.9x
Molecular docking speed improvement6.2 times faster
Show all 6 reported metrics
protein structure prediction speedupup to 5x
target identification timelinefeasible in days rather than months
RFdiffusion inference speedup1.9x
molecular docking speed improvement6.2 times faster
molecular docking accuracy improvement16%
wet-lab experiment dependencyreducing the need for costly wet-lab experiments
Reported stack
BioNeMoAlphaFold2RFdiffusionProteinMPNNDiffDock 2.0ESM-1nvESM-2Clara DiscoveryBioPhiEfficient Evolution
Source
https://mlops.community/blog/generative-ai-for-protein-binder-design
Read source ↗

Frequently asked questions

What did this team achieve with this AI workflow?

The BioNeMo pipeline achieves up to 5x speedup in protein structure prediction (days rather than months), 1.9x faster backbone generation with RFdiffusion, and 6.2x faster molecular docking at 16% greater accuracy wit…

What tools did this team use?

BioNeMo, AlphaFold2, RFdiffusion, ProteinMPNN, DiffDock 2.0, ESM-1nv, ESM-2, Clara Discovery, BioPhi, Efficient Evolution.

What results were reported?

Protein structure prediction speedup: up to 5x; Target identification timeline: feasible in days rather than months; RFdiffusion inference speedup: 1.9x; Molecular docking speed improvement: 6.2 times faster (source-reported, not independently verified).

How is this workflow AI workflow structured?

Target structure prediction → De novo binder backbone and sequence generation → Molecular docking prediction → Stability validation → Functional testing and refinement → High-throughput in silico screening.